Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling
- PMID: 15769747
- DOI: 10.1074/jbc.M500747200
Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling
Abstract
Activated protein C (APC) has anti-inflammatory and vascular protective effects independent of anticoagulation. We previously identified the prototypical thrombin receptor, protease-activated receptor-1 (PAR1), as part of a novel APC-endothelial cell protein C receptor (EPCR) signaling pathway in endothelial cells. Experiments in wild-type and PAR1(-/-) mice demonstrated that intravenous injection of APC leads to PAR1-dependent gene induction in the lung. The vascular endothelium undergoes profound changes in severe sepsis, the approved therapeutic indication for APC. Similar to PAR1, APC activated PAR2 through canonical cleavage. Although PAR2 was up-regulated in cytokine-stimulated endothelial cells, APC signaling remained PAR1-dependent. Large scale gene expression profiling documented marked differences in both up- and down-regulated genes between APC and thrombin signaling in cytokine-stimulated cells. APC down-regulated transcripts for proapoptotic proteins including p53 and thrombospondin-1, but p53 was unchanged, and thrombospondin was even up-regulated by thrombin. Concordant PAR1-dependent effects on protein levels were found. Thus, by signaling through the same receptor PAR1, APC, and thrombin can exert distinct biological effects in perturbed endothelium. These data may explain how APC can be therapeutically protective through the EPCR-PAR1 signaling despite ongoing thrombin generation due to disseminated intravascular coagulopathy.
Similar articles
-
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.J Endotoxin Res. 2003;9(5):317-21. doi: 10.1179/096805103225002584. J Endotoxin Res. 2003. PMID: 14577849
-
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.J Thromb Haemost. 2017 Nov;15(11):2198-2207. doi: 10.1111/jth.13807. Epub 2017 Sep 21. J Thromb Haemost. 2017. PMID: 28834159
-
Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.Blood. 2016 Oct 6;128(14):1884-1893. doi: 10.1182/blood-2016-06-720581. Epub 2016 Aug 25. Blood. 2016. PMID: 27561318 Free PMC article.
-
A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.Biochemistry (Mosc). 2017 Jul;82(7):778-790. doi: 10.1134/S0006297917070033. Biochemistry (Mosc). 2017. PMID: 28918742 Review.
-
The occupancy of endothelial protein C receptor by its ligand modulates the par-1 dependent signaling specificity of coagulation proteases.IUBMB Life. 2011 Jun;63(6):390-6. doi: 10.1002/iub.447. Epub 2011 Mar 24. IUBMB Life. 2011. PMID: 21438119 Free PMC article. Review.
Cited by
-
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.Biologics. 2009;3:391-406. doi: 10.2147/btt.2009.3547. Epub 2009 Sep 15. Biologics. 2009. PMID: 19774207 Free PMC article.
-
Differential signaling by protease-activated receptors: implications for therapeutic targeting.Int J Mol Sci. 2014 Apr 11;15(4):6169-83. doi: 10.3390/ijms15046169. Int J Mol Sci. 2014. PMID: 24733067 Free PMC article. Review.
-
Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.Ann N Y Acad Sci. 2016 Apr;1370(1):65-81. doi: 10.1111/nyas.13013. Epub 2016 Mar 1. Ann N Y Acad Sci. 2016. PMID: 26928241 Free PMC article. Review.
-
Protease-activated receptors and prostaglandins in inflammatory lung disease.Br J Pharmacol. 2009 Oct;158(4):1017-33. doi: 10.1111/j.1476-5381.2009.00449.x. Br J Pharmacol. 2009. PMID: 19845685 Free PMC article. Review.
-
Protective mechanisms of activated protein C in severe inflammatory disorders.Br J Pharmacol. 2009 Oct;158(4):1034-47. doi: 10.1111/j.1476-5381.2009.00251.x. Epub 2009 May 14. Br J Pharmacol. 2009. PMID: 19466992 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous